These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2428248)

  • 1. CA 125 in gynecologic practice.
    Malkasian GD; Podratz KC; Stanhope CR; Ritts RE; Zurawski VR
    Am J Obstet Gynecol; 1986 Sep; 155(3):515-8. PubMed ID: 2428248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
    Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
    Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report.
    Patsner B; Mann WJ
    Cancer; 1988 Oct; 62(7):1355-8. PubMed ID: 3166396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
    Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
    Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA-125 in gynecological malignancies.
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.
    Jäger W; Adam R; Wildt L; Lang N
    Arch Gynecol Obstet; 1988; 243(2):91-9. PubMed ID: 2456743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy.
    Pansini F; Bellinazzi A; Rainaldi V; Santoiemma M; Lenzi B; Jacobs M; Mollica G; Bagni B
    Gynecol Obstet Invest; 1986; 21(1):47-51. PubMed ID: 3005141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.
    Patsner B; Mann WJ; Cohen H; Loesch M
    Am J Obstet Gynecol; 1988 Feb; 158(2):399-402. PubMed ID: 2449079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer.
    Niloff JM; Knapp RC; Lavin PT; Malkasian GD; Berek JS; Mortel R; Whitney C; Zurawski VR; Bast RC
    Am J Obstet Gynecol; 1986 Jul; 155(1):56-60. PubMed ID: 3460341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA125 as a serum marker for poor prognosis in ovarian malignancies.
    Alvarez RD; To A; Boots LR; Shingleton HM; Hatch KD; Hubbard J; Soong SJ; Potter ME
    Gynecol Oncol; 1987 Mar; 26(3):284-9. PubMed ID: 2435619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
    Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
    Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
    McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
    Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.